These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7029792)
1. Role of prostaglandin I2 and thromboxane A2 in recurring reduction of carotid and cerebral blood flow in dogs. Uchida Y; Murao S Stroke; 1981; 12(6):786-92. PubMed ID: 7029792 [TBL] [Abstract][Full Text] [Related]
2. Roles of endogenous prostacyclin and thromboxane A2 in the ischemic canine heart. Sakai K; Ito K; Ogawa K J Cardiovasc Pharmacol; 1982; 4(1):129-35. PubMed ID: 6176788 [TBL] [Abstract][Full Text] [Related]
3. Effects of thromboxane synthetase inhibitors on cyclical reduction of coronary blood flow in dogs. Uchida Y; Murao S Jpn Heart J; 1981 Nov; 22(6):971-5. PubMed ID: 7040725 [TBL] [Abstract][Full Text] [Related]
4. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation. Gryglewski RJ; Dembínska-Kieć A; Korbut R Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254 [TBL] [Abstract][Full Text] [Related]
5. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence. Miller OV; Ayer DE; Gorman RR Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs. Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650 [TBL] [Abstract][Full Text] [Related]
7. Role of the prostaglandin-thromboxane system in the development and maintenance of spontaneous hypertension in the rat. Yasujima M; Abe K; Tanno M; Kohzuki M; Sato M; Omata K; Takeuchi K; Hagino T; Yoshinaga K Agents Actions Suppl; 1987; 22():133-8. PubMed ID: 3124554 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandins and angioplasty. An experimental study in canine arteries. Zollikofer CL; Cragg AH; Einzig S; Castaneda-Zuniga WR; Castaneda F; Rysavy JA; Bruhlmann WF; Shebuski RJ; Amplatz K Radiology; 1983 Dec; 149(3):681-5. PubMed ID: 6227930 [TBL] [Abstract][Full Text] [Related]
10. Effects of a thromboxane A2-receptor antagonist, a thromboxane synthetase inhibitor and aspirin on prostaglandin I2 production in endothelium-intact and -injured aorta of guinea pigs. Higo K; Karasawa A Jpn J Pharmacol; 1994 Dec; 66(4):471-9. PubMed ID: 7723224 [TBL] [Abstract][Full Text] [Related]
11. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides. Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780 [TBL] [Abstract][Full Text] [Related]
12. Orchidectomy increases the formation of prostanoids and modulates their role in the acetylcholine-induced relaxation in the rat aorta. Martorell A; Blanco-Rivero J; Aras-López R; Sagredo A; Balfagón G; Ferrer M Cardiovasc Res; 2008 Feb; 77(3):590-9. PubMed ID: 18006440 [TBL] [Abstract][Full Text] [Related]
13. Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries. Shirahase H; Usui H; Manabe K; Kurahashi K; Fujiwara M J Pharmacol Exp Ther; 1989 Feb; 248(2):769-73. PubMed ID: 2645398 [TBL] [Abstract][Full Text] [Related]
14. [Role of prostacyclin and thromboxane A2 in the cardiovascular system]. Ismailov ShI; Val'dman AV Kardiologiia; 1981 Mar; 21(3):111-6. PubMed ID: 7014974 [No Abstract] [Full Text] [Related]
15. The role of prostacyclin and thromboxane in sepsis and septic shock. Carmona RH; Tsao TC; Trunkey DD Arch Surg; 1984 Feb; 119(2):189-92. PubMed ID: 6365031 [TBL] [Abstract][Full Text] [Related]
16. Possible role of endothelial thromboxane A2 in the resting tone and contractile responses to acetylcholine and arachidonic acid in canine cerebral arteries. Shirahase H; Usui H; Kurahashi K; Fujiwara M; Fukui K J Cardiovasc Pharmacol; 1987 Nov; 10(5):517-22. PubMed ID: 2447399 [TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of prostaglandins and other arachidonic acid metabolites. Prostacyclin (PGI2), thromboxane A2, leukotriene]. Oelz O Ther Umsch; 1982 Oct; 39(10):751-8. PubMed ID: 6760444 [No Abstract] [Full Text] [Related]
18. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279 [TBL] [Abstract][Full Text] [Related]
19. Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits. Fink MP; Morrissey PE; Stein KL; Clement RE; Fiallo V; Gardiner WM Circ Shock; 1988 Sep; 26(1):41-57. PubMed ID: 3142697 [TBL] [Abstract][Full Text] [Related]
20. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets. de Chaffoy de Courcelles D; De Clerck F Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]